Contact Us: 734-712-3456

NCI Community Oncology Research Program
For more information and
a full list of clinical trials,
visit mcrconline.org

Clinical trials are key to developing new methods to prevent, detect, and treat cancer. It is through clinical trials that researchers can determine whether new treatments are safe and effective and work better than current treatments. When you take part in a clinical trial, you add to our knowledge about cancer and help improve cancer care.  This also allows patients access to treatments of the future. The advancements in cancer treatments made through clinical trials are helping patients live longer.

What is a clinical trial?

A clinical trial is the final step in a long process that begins with laboratory research on new treatments. Before a treatment can be used for a clinical trial on people, it must be proven in the lab that it has strong potential to be better than the current standard of care. In a clinical trial, participants receive standard treatment for their cancer and/or may receive a promising treatment that is felt to be just as good if not better than the current standard of care.

2015 Research Study Overview

Type of Research Study

# of Subjects Consented and Enrolled

Clinical Trials

148

Prevention and Control Research studies

78

Quality of Life and Economics of Care Studies

40

Bio-Repository/ Bio-Bank Studies

242

Patient Registry Studies

450

Total

958

NCI Community Oncology Research Program

In 2014, St. Joe's was awarded a five-year, $11 million grant by the National Cancer Institute (NCI) as a member of the National Cancer Institute Community Oncology Program (NCORP). The grant allows St. Joe's, as the administrative hub, to assist 14 other consortium partners to provide their patients access to clinical trials.  At any given time there are more than 100 open studies for new patients and over 350 studies in follow-up.  In 2014, more than 958 patients took part in clinical trials, bio-repository studies and registries. In 2015, St. Joe's was recognized as a leader in Precision Medicine Trials, a high priority for the National Institute of Health (NIH). 

The NCORP program at St. Joe’s – one of only 34 in the country – was the only program in the nation to receive the highest ranking and a perfect score in every category as part of the National Cancer Institute’s stringent proposal process, earning our Cancer Center one of the largest grant awards among NCORP designees and the leverage to make the biggest difference for our patients.  St. Joe’s NCORP program, known as the Michigan Cancer Research Consortium, is made up of 14 cancer centers, extending the support and benefits of our expertise to patients and staff at locations throughout Michigan and nationally.

Our oncologists have access to leading-edge treatments and experimental medications. SJMHS offers clinical trials at all phases of development. Patients have access to clinical trials being offered at top cancer centers such as M.D. Anderson and Mayo Clinic. 

Our commitment to research also enables us to continuously study the quality of clinical outcomes. We examine and evaluate standards on an ongoing basis, and implement proven systems and processes to enhance treatment quality.

To learn more about research trials and if you qualify, please contact 734-712-5658.

Conflict of Interest

For a copy of the Financial Conflict of interest Policy for the St. Joseph Mercy Ann Arbor, Chelsea, Livingston and Livonia locations that addresses disclosures by investigators and associates engaged in clinical research, please click here.

For inquiries concerning any financial conflict of interest pertaining to federally funded clinical research at SJMHS, please submit a request to aasjirbsubmissions@stjoeshealth.org

SJMHS will provide the requested information within five business days.  

Click here to download the Federal Register Rule on Promoting Objectivity in Research- Financial Interest Disclosure.